1.
Rev. Soc. Esp. Dolor
; 26(2): 124-125, mar.-abr. 2019. ilus
Artigo
em Espanhol
| IBECS
| ID: ibc-190885
RESUMO
En los estudios clínicos en los que se ha utilizado pregabalina para el dolor neuropático se concluye que es un fármaco seguro. Sin embargo durante la experiencia postcomercialización se han notificado casos de insuficiencia cardiaca congestiva
In all clinical studies that pregabalin has been used for the treatment of neuropathic pain it is concluded that it is a drug insurance. However, during the post-marketing experience they have been reported cases of congestive heart failure